Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 401–500 of 777
Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
Hey, G. E., Nair, N., Klann, E. M., Gurrala, A., Safarpour, D., Mai, V., Ramirez‐Zamora, A., & Vedam‐Mai, V. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1151850 · Cited by 28
“Prevotella is a mucin-degrader that promotes and serves as an indicator of gut integrity (Brown et al., 2011) nevertheless, it has also been linked to gut inflammation and systemic inflammatory conditions (Ganesh et al.”
BackgroundGut microbiome and blood glucose control in type 1 diabetes: a systematic review
Abuqwider, J., Corrado, A., Scidà, G., Lupoli, R., Costabile, G., Mauriello, G., & Bozzetto, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265696 · Cited by 34
Early life origin of type 1 diabetes
Knip, M., Luopajärvi, K., & Härkönen, T. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0665-6 · Cited by 35
Self-citationThe menstrual cycle may not be limited to the endometrium but also may impact gut permeability
Roomruangwong, C., Carvalho, A. F., Geffard, M., & Maes, M. H. J. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.30 · Cited by 28
“Prevotella is associated with increased gut permeability since it may degrade mucin (Brown et al., 2011), whereas Clostridiales, Ruminococcus and Lachnospiraceae are butyrate-producing bacteria, which play a role in maintaining gut homeostasis (Hamer et al.”
BackgroundRWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction
Niu, Y., Qu, C., Wang, G., & Yan, G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01578 · Cited by 33
“…between microbial dysbiosis and various human diseases (Neish, 2009), such as inflammatory bowel disease (IBD) (Frank et al., 2007), diabetes (Brown et al., 2011; Giongo et al., 2011), asthma (Chen and Blaser, 2007), obesity (Ley et al., 2006), and some cancers (Moore and Moore, 1995;…”
BackgroundIn vitro analysis of partially hydrolyzed guar gum fermentation on identified gut microbiota
Carlson, J. L., Gould, T. J., & Slavin, J. L. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.08.006 · Cited by 31
Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases
Wang, L., Xu, H., Yang, H., Zhou, J., Zhao, L., & Zhang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952398 · Cited by 36
Microbiota: A potential orchestrator of antidiabetic therapy
Liu, B., Zhang, L., Yang, H., Zheng, H., & Liao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.973624 · Cited by 31
“Compared with controls, 16S rRNA data of individuals with T1D showed a lower proportion of butyrateproducing and mucin-degrading bacteria (28), and fecal microbiota transplantation (FMT) from healthy donors halted the decline in endogenous insulin production in new-onset T1D patients (31).”
ResultGut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease
Koshida, T., Gohda, T., Sugimoto, T., Asahara, T., Asao, R., Ohsawa, I., Gotoh, H., Murakoshi, M., Suzuki, Y., & Yamashiro, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411456 · Cited by 32
“edu/lefse/) was applied to analyze the characteristics of the fecal microbiome in each group [39]; the effect size of each feature was evaluated via linear discriminant analysis (LDA), with a log(LDA) score of 3.”
MethodApplications of Genome-Editing Technologies for Type 1 Diabetes
Nahas, R. E., Al‐Aghbar, M. A., Herrero, L., van Panhuys, N., & Espino‐Guarch, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010344 · Cited by 31
“Others have suggested a bacterial role in the development of T1D, in which butyrate-producing lactate-utilizing bacteria disrupt mucin synthesis in the gut, leading to autoimmune disorders, particularly T1D [16].”
Metabolomics in the Studies of Islet Autoimmunity and Type 1 Diabetes
Orešič, M. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.236 · Cited by 29
“Recent data also suggest that children who later progress to T1D have an altered microbiota with a deficit in butyrate-producing bacteria [48, 49].”
BackgroundMobile Technologies for the Discovery, Analysis, and Engineering of the Global Microbiome
Ballard, Z. S., Brown, C., & Özcan, A. (2018) · ACS Nano · doi:10.1021/acsnano.7b08660 · Cited by 28
Self-citationThe antigenic link between thyroid autoimmunity and breast cancer
Muller, I., & Barrett-Lee, P. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.013 · Cited by 27
The impact of probiotic Clostridium butyricum MIYAIRI 588 on murine gut metabolic alterations
Hagihara, M., Yamashita, R., Matsumoto, A., Mori, T., Inagaki, T., Nonogaki, T., Kuroki, Y., Higashi, S., Oka, K., Takahashi, M., et al. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.02.008 · Cited by 28
Microbiome based precision medicine through integrated multiomics and machine learning
Kumar, A., Xu, C., & Dakal, T. C. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128384 · Cited by 28
Santilli, A. D., Dawson, E. M., Whitehead, K. J., & Whitehead, D. C. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00309 · Cited by 29
Holistic perspective of the role of gut microbes in diabetes mellitus and its management
Alagiakrishnan, K., & Halverson, T. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i9.1463 · Cited by 29
Chen, Q., Sun, S., Mei, C., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2022) · Environment International · doi:10.1016/j.envint.2022.107388 · Cited by 26
Gut microbiome in type 1 diabetes: the immunological perspective
Rampanelli, E., & Nieuwdorp, M. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2150612 · Cited by 32
“in the microbiome of T1D patients [84].”
BackgroundComparative Analysis of Gut Microbiota between Wild and Captive Golden Snub-Nosed Monkeys
Wang, Y., Yang, X., Zhang, M., & Pan, H. (2023) · Animals · doi:10.3390/ani13101625 · Cited by 27
Transcriptomic changes in an animal-bacterial symbiosis under modeled microgravity conditions
Casaburi, G., Goncharenko-Foster, I., Duscher, A. A., & Foster, J. S. (2017) · Scientific Reports · doi:10.1038/srep46318 · Cited by 26
Khan, I., Yasir, M., Farman, M., Kumosani, T., AlBasri, S. F., Bajouh, O. S., & Azhar, E. I. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s200213 · Cited by 25
“copri is one of the dominant human gut bacteria,(57) which is comparatively more abundant in non-Westerners(5) and improves intestinal permeability by degrading mucin.(58) The family Ruminococcaceae was discriminately enriched in third trimester samples.”
BackgroundThe gut microbiota perspective for interventions in MS
Żołędziewska, M. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.016 · Cited by 26
Effects of Type 1 Diabetes Risk Alleles on Immune Cell Gene Expression
Ram, R., & Morahan, G. (2017) · Genes · doi:10.3390/genes8060167 · Cited by 27
“study [35] into a possible bacterial role in developing T1D, sequencing of fecal samples showed a higher number of reads mapping to sulfur metabolism in T1D cases compared to that of controls, suggesting interaction of microbiome and sulphur metabolism genes.”
ResultThe etiology of autoimmune diseases: the case of myasthenia gravis
Bach, J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06774.x · Cited by 26
Wang, Y., Tian, L., Fabi, J. P., & de Vos, P. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107539 · Cited by 28
Changes in Gut Microorganism in Patients with Positive Immune Antibody‐Associated Recurrent Abortion
Jin, M., Li, D., Ji, R., Liu, W., Xu, X., & Feng, X. (2020) · BioMed Research International · doi:10.1155/2020/4673250 · Cited by 26
Mrozińska, S., Kapusta, P., Gosiewski, T., Sroka-Oleksiak, A., Ludwig‐Słomczyńska, A. H., Matejko, B., Kieć‐Wilk, B., Bulanda, M., Malecki, M. T., Wołkow, P. P., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9010155 · Cited by 28
Guts, Germs, and Meals: The Origin of Type 1 Diabetes
Beyan, H., Li, W., & Leslie, R. D. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0298-z · Cited by 27
Association of diabetes and microbiota: An update
Al-Jameel, S. S. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.04.041 · Cited by 25
“But the ratio of other short chain fatty acid producing bacteria were higher in a case study (Brown et al., 2011).”
BackgroundKiefer, Z. E., Koester, L. R., Studer, J. M., Chipman, A., Mainquist‐Whigham, C., Keating, A. F., Schmitz‐Esser, S., & Ross, J. W. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab178 · Cited by 28
Effects of Hydroxy-Alpha-Sanshool on Intestinal Metabolism in Insulin-Resistant Mice
Xu, F., Zhu, Y., Lu, M., Qin, L., Zhao, D., & Ren, T. (2022) · Foods · doi:10.3390/foods11142040 · Cited by 23
“The intestinal microbiota and metabolites stimulate the body to produce cytokines, affecting glucose metabolism and insulin sensitivity in the body [8,9].”
BackgroundHayer, S. S., Conrin, M. E., French, J. A., Benson, A. K., Alvarez, S., Cooper, K. M., Fischer, A., Alsafwani, Z. W., Gasper, W., Haute, M. J. S. V., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2305476 · Cited by 24
Zhao, F., Gong, Z., Yang, Y., Li, X., Chen, D., Shi, X., Yu, T., & Wei, P. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.173417 · Cited by 25
Microbiota signatures in type-2 diabetic patients with chronic kidney disease - A Pilot Study
Pîrcălăbioru, G. G., Stoica, R. A., Petcu, L. M., Picu, A. A., Suceveanu, A. P., Salmen, T., Stefan, D., Serafinceanu, C., Chifiriuc, M. C., & Stoian, A. P. (2019) · Journal of Mind and Medical Sciences · doi:10.22543/7674.61.p130136 · Cited by 23
“(19) and also butyrate-producing microorganisms, such as Faecalibacterium prausnitzii,”
BackgroundGut Microbiota and Endocrine Disorder
Li, R., Li, Y., Cui, L., Zheng, D., & Chen, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_9 · Cited by 24
Epigenetic Effects of Gut Metabolites: Exploring the Path of Dietary Prevention of Type 1 Diabetes
Theyab, A. A., Almutairi, T., Al-Suwaidi, A. M., Bendriss, G., McVeigh, C., & Châari, A. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.563605 · Cited by 23
“In fact, Bacteroides are proposed to contribute to chronic inflammation by the impairment of the barrier function of the epithelial cell layer (82).”
BackgroundVirus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes
Morse, Z. J., & Horwitz, M. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751337 · Cited by 28
Das, S., & Ramanathan, G. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121414 · Cited by 24
Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship
Piccioni, A., Rosa, F., Mannucci, S., Manca, F., Merra, G., Chiloiro, S., Candelli, M., Covino, M., Gasbarrini, A., & Franceschi, F. (2023) · Biomedicines · doi:10.3390/biomedicines11030707 · Cited by 25
“Researchers have long hypothesized that patients with type 1 diabetes mellitus might have a different composition of the gut microbiota than that of healthy people [32].”
BackgroundEmani, R., Asghar, M. N., Toivonen, R. K., Lauren, L., Söderström, M., Toivola, D. M., van Tol, E. A. F., & Hänninen, A. L. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2941-x · Cited by 23
“Recent investigations into gut microbiota have revealed qualitative differences in the composition of bacterial species between children who develop and those who do not develop type 1 diabetes [7, 8].”
InfluentialSasaki, H., Kawamura, K., Kawamura, T., Odamaki, T., Katsumata, N., Xiao, J., Suzuki, N., & Tanaka, M. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.12.026 · Cited by 26
Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study
Abdellatif, A. M., Smith, H. J., Harms, R. Z., & Sarvetnick, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02623 · Cited by 25
Reyer, H., Oster, M., McCormack, U. M. M., Muráni, E., Gardiner, G. E., Ponsuksili, S., Lawlor, P. G., & Wimmers, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040563 · Cited by 24
“Specifically, various Rothia species support the digestion of gluten proteins from feedstuffs [34], Subdoligranulum species contribute to the conversion of lactate to butyrate [35] and the RC9 gut group has been proposed as part of the core microbiota [36], associated with the turnover of starch and non-starch polysac…”
BackgroundGut microbiota and metabolic disease: from pathogenesis to new therapeutic strategies
Kang, Y., Zhang, X., Cai, Y., Su, J., & Kong, X. (2016) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000085 · Cited by 20
The role and molecular mechanism of gut microbiota in Graves’ orbitopathy
Li, Y., Luo, B., Tong, B., Xie, Z., Cao, J., Bai, X., Peng, Y., Wu, Y., Wang, W., & Qi, X. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01902-7 · Cited by 22
“Bacteroides can produce short-chain fatty acids other than butyric acid, including succinic, propionic, and acetic acids; these fatty acids will not induce mucin synthesis, leading to decreased intestinal tight junctions and increased intestinal mucosal permeability [56].”
BackgroundLiu, J., Zhou, L., Sun, L., Ye, X., Ma, M., Dou, M., & Shi, L. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s412872 · Cited by 21
Gorini, F., & Tonacci, A. (2024) · Nutrients · doi:10.3390/nu16111762 · Cited by 25
“Fermentation of glucose and lactate by Bacteroides produces propionate, acetate, and succinate, which, since not being able to induce mucin synthesis unlike butyrate, may result in a reduction of intestinal tight junctions and increased permeability of the intestinal mucosa [79,106].”
BackgroundThe Role of Toll‐Like Receptors and Vitamin D in Diabetes Mellitus Type 1 – A Review
Adamczak, D., Nowak, J. K., Frydrychowicz, M., Kaczmarek, M., & Sikora, J. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12188 · Cited by 23
Romano-Keeler, J., Weitkamp, J.-H., & Moore, D. J. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283514d43 · Cited by 21
Hu, T., Wen, P., Liu, J., Long, X., Liao, S., Wu, H., & Zou, Y. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103503 · Cited by 21
A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis
Hamilton‐Williams, E. E., Lorca, G. L., Norris, J. M., & Dunne, J. L. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.600756 · Cited by 23
Ma, W., Huang, C., Zhou, Y., Li, J., & Cui, Q. (2017) · Scientific Reports · doi:10.1038/srep40200 · Cited by 20
“In type 1 diabetes, the butyrate-producing and lactate-utilizing bacteria were reduced 6 .”
BackgroundGut microbiome differences among Mexican Americans with and without type 2 diabetes mellitus
Kitten, A., Ryan, L., Lee, G. C., Flores, B. E., & Reveles, K. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251245 · Cited by 22
“Although alpha diversity has been shown to be a marker of multiple diseases, including obesity [20], colorectal cancer [21], and type 1 diabetes [22], multiple gut microbiome studies in T2DM demonstrated that alpha diversity is not significantly different between well-matched subjects with and without T2DM [5, 7].”
BackgroundLinking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function
Hassouneh, S. A.-D., Loftus, M. G., & Yooseph, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.673632 · Cited by 22
Al-Kader, D. A., Asadi, N., Solangi, U., Singh, R., Rasuli, S. F., Farooq, M. J., Raheela, F., Waseem, R., Gilani, S. M., Abbas, K., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1238146 · Cited by 23
RetractedPredicting the role of the human gut microbiome in type 1 diabetes using machine-learning methods
Liu, X., Li, H., Ma, C.-Y., Shi, T., Wang, T., Yan, D., Tang, H., Lin, H., & Deng, K. (2024) · Briefings in Functional Genomics · doi:10.1093/bfgp/elae004 · Cited by 20
Gut Microbiota Composition and Its Metabolites in Different Stages of Chronic Kidney Disease
Chen, T.-H., Liu, C.-W., Ho, Y.-H., Huang, C.-K., Hung, C.-S., Smith, B. H., & Lin, J.-C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173881 · Cited by 21
“The richness of genera Roseburia, Faecalibacterium, or Bifidobacteria has been correlated with increased levels of butyrate [34,35], a short chain fatty acid, which strengthens the integrity of gut barrier through stable tight and efficient mucus production [36,37].”
BackgroundHill, A. E., Wade‐Martins, R., & Burnet, P. W. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.708587 · Cited by 20
Swaminathan, G., Citron, M. P., Xiao, J., Norton, J. E., Reens, A. L., Topçuoğlu, B. D., Maritz, J. M., Lee, K.-J., Freed, D. C., Weber, T. M., et al. (2021) · Vaccines · doi:10.3390/vaccines9111340 · Cited by 19
CHIERICO, F. D., Conta, G., Matteoli, M. C., Fierabracci, A., Reddel, S., Macari, G., Gardini, S., Guarrasi, V., Mortera, S. L., Marzano, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810256 · Cited by 19
“These findings reflect the alteration of gut microbiota in T1D patients, involving butyrate and lactate producers as well as the mucin degraders [19,20].”
BackgroundInfluentialMortera, S. L., Marzano, V., Vernocchi, P., Matteoli, M. C., Guarrasi, V., Gardini, S., CHIERICO, F. D., Rapini, N., Deodati, A., Fierabracci, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415982 · Cited by 19
“prausnitzii, which is a direct butyrate producer, were decreased in T1D when compared with CTRL, mainly associated with purine and pyruvate metabolisms (Figure 3A) [45,46].”
BackgroundDietary habits and Helicobacter pylori infection: is there an association?
Soares, G. A. S., Moraes, F. A. D. S., Ramos, A. F. P. L., Santiago, S. B., Germano, J. N., Fernandes, G. A., Curado, M. P., & Barbosa, M. S. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231160620 · Cited by 18
Ortí, J. E. D. L. R., Moneti, C., Serrano-Ballesteros, P., Castellano, G., Bayona-Babiloni, R., Carriquí-Suárez, A. B., Motos-Muñoz, M., Proaño, B., & Benlloch, M. (2023) · Nutrients · doi:10.3390/nu15143265 · Cited by 20
Cossu, A., Ferrannini, E., Fallahi, P., Antonelli, A., & Sechi, L. A. (2012) · Cytokine · doi:10.1016/j.cyto.2012.11.008 · Cited by 18
“Environmental trigger factors including microbial agents [2] have been suggested as causative agents for the development of the autoimmune disease.”
BackgroundMetabolomics to identify biomarkers and as a predictive tool in inflammatory diseases
Jutley, G. S., & Young, S. P. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.02.010 · Cited by 21
Targeting gut microbiota: a potential promising therapy for diabetic kidney disease.
Chen, Z., Zhu, S., & Xu, G. (2016) · PubMed Central · Cited by 20
Gut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 21
The Role of Nutri(epi)genomics in Achieving the Body’s Full Potential in Physical Activity
Petracci, I., Gabbianelli, R., & Bordoni, L. (2020) · Antioxidants · doi:10.3390/antiox9060498 · Cited by 20
“Diet is a key factor in the establishment of the gut microbiota composition and in the shaping of the host’s metabolism [271,277].”
BackgroundFriendly pathogens: prevent or provoke autoimmunity
Sathyabama, S., Khan, N., & Agrewala, J. N. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.787043 · Cited by 20
“Increased adhesion and flagella synthesis by the gut microbes may be involved in triggering a T1D associated autoimmune response (Brown et al., 2011).”
BackgroundImplication of epigenetic factors in the pathogenesis of type 1 diabetes
Zhang, J., Chen, L., Zou, Y., Zhang, S., Xiong, F., & Wang, C. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001450 · Cited by 24
McCune, E., Sharma, A., Johnson, B., O’Meara, T. A., Theiner, S., Campos, M., Heditsian, D. M., Brain, S., Gilbert, J. A., Esserman, L. J., et al. (2024) · mSystems · doi:10.1128/msystems.01237-24 · Cited by 18
“Alterations in these microbial communities have been linked to a variety of diseases, including inflammatory bowel disease (7, 8), obesity (9), diabetes (10, 11), rheumatoid arthritis (12), cardiovascular diseases (13), and cancer (14–20).”
Riva, A. D., Wållberg, M., Ronchi, F., Coulson, R., Sage, A., Thorne, L., Goodfellow, I., McCoy, K. D., Azuma, M., Cooke, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181964 · Cited by 18
Defining Dysbiosis in Disorders of Movement and Motivation
Fields, C. T., Sampson, T. R., Bruce‐Keller, A. J., Kiraly, D. D., Hsiao, E. Y., & Vries, G. J. D. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1672-18.2018 · Cited by 21
“For example, as discussed for PD, Prevotella levels are inversely correlated with gut barrier permeability (Brown et al., 2011; Forsyth et al., 2011; Cakmak, 2015).”
BackgroundThe early years of life. Are they influenced by our microbiome?
Jagodziński, A., Zielińska, E., Łaczmański, Ł., & Hirnle, L. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0041 · Cited by 26
“pl/ginekologia_polska scientists’ attention is drawn to the role of the microbiome in neuropsychiatry [35].”
Altered Systemic and Intestinal IgA Immune Responses in Individuals With Type 1 Diabetes
Huang, J., Huang, G., Li, X., Hu, F., Xie, Z., Xiao, Y., Luo, S., Chao, C., Guo, K., Wong, F. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa590 · Cited by 17
“Increasing numbers of studies have demonstrated that individuals with type 1 diabetes have different compositions of gut microbiota compared with healthy control participants (38-40).”
Zhu, C., Wang, X., Li, J., Jiang, R., Chen, H., Chen, T., & Yang, Y. (2022) · BMC Microbiology · doi:10.1186/s12866-021-02414-9 · Cited by 18
“According to the previous research, 323 Bacteroides genus was associated with several human diseases, including five gut diseases 324 (irritable bowel syndrome (28), Clostridium difficile infection (31), colorectal carcinoma 325 (33), Crohn's disease (34, 35) and infectious colitis (36)), type 1 diabetes (29, 30) and…”
BackgroundSafari‐Alighiarloo, N., Emami, Z., Rezaei–Tavirani, M., Alaei-Shahmiri, F., & Razavi, S. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0049 · Cited by 20
Ismail, H. M., Spall, M., Evans‐Molina, C., & DiMeglio, L. A. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01373-4 · Cited by 18
“• Additional metagenomic sequencing will be performed [28, 29].”
BackgroundEvidence for the Role of the Cecal Microbiome in Maintenance of Immune Regulation and Homeostasis
Chhabra, P., Spano, A., Bowers, D. T., Ren, T., Moore, D. J., Timko, M. P., Wu, M., & Brayman, K. L. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002930 · Cited by 17
Harbison, J. E., Thomson, R. L., Wentworth, J. M., Louise, J., Roth‐Schulze, A. J., Battersby, R., Ngui, K., Penno, M. A. S., Colman, P. G., Craig, M. E., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13178 · Cited by 17
Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome
Ji, Y. S., Yang, Y., & Wu, Z. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106436 · Cited by 20
Liu, X.-R., Lü, X., Nie, H., Yan, J., Ma, Z., Li, H., Tang, S., Yin, Q., & Qiu, J. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250229 · Cited by 16
Deng, J., Luo, K., Chen, X., Zhu, Y., Xiang, Z., Zhu, B., Tang, X., Zhang, T., Shi, L., Lyu, X., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27145 · Cited by 17
“Bacteroidetes was reported in children who developed T1DM [50].”
BackgroundBeldie, L.-A., Dica, C.-C., Moța, M., Pirvu, B.-F., Burticală, M.-A., Mitrea, A., Clenciu, D., Efrem, I. C., Vladu, B. E., Timofticiuc, D. C. P., et al. (2024) · Nutrients · doi:10.3390/nu16234131 · Cited by 17
Gut Immunity and Type 1 Diabetes: a Mélange of Microbes, Diet, and Host Interactions?
Endesfelder, D., Engel, M., & zu Castell, W. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0753-3 · Cited by 17
Sané, F., Scuotto, A., Pierrat, V., Kacet, N., Hober, D., & Romond, M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.017 · Cited by 18
Feng, H., Qu, H., Liu, Y., Shi, Y., Wu, S., & Bao, W. (2020) · Revista Brasileira de Zootecnia · doi:10.37496/rbz4920190096 · Cited by 17
Multi-omic interactions in the gut of children at the onset of islet autoimmunity
Gavin, P. G., Kim, K. W., Craig, M. E., Hill, M. M. C., & Hamilton‐Williams, E. E. (2022) · Microbiome · doi:10.1186/s40168-022-01425-6 · Cited by 18
“Faecalibacterium and unclassified Ruminococcaceae OTUs were observed at lower relative abundance in children who develop autoimmunity in some small case control studies [49, 54] and in the much larger TEDDY longitudinal study [29].”
BackgroundGuo, K., Li, J., Li, X., Huang, J., & Zhou, Z. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1137595 · Cited by 19
Taneja, V. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00027-9 · Cited by 21
Dietary SCFAs Immunotherapy: Reshaping the Gut Microbiota in Diabetes
Yap, Y. A., & Mariño, E. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_515 · Cited by 19
Lakshmanan, A. P., Kohil, A., Assadi, F. E., Zaidan, S. A., Alabduljabbar, S., Bangarusamy, D. K., Khalaf, F. A., Petrovski, G., & Terranegra, A. (2021) · Nutrients · doi:10.3390/nu13030836 · Cited by 17
“The Bio-Breeding Diabetic Prone (BBdp) rats have shown that mucin reduction increases the susceptibility to T1DM [48].”
BackgroundAdvances in the Pathogenesis and Treatment Strategies for Type 1 Diabetes Mellitus
Du, M., Li, S., Jiang, J., Ma, X., Liu, L., Wang, T., Zhang, J., & Niu, D. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114185 · Cited by 18
Wang, L., He, X., Zhang, Z., & Chen, N. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.04.004 · Cited by 18
Type 1 diabetes: a disease of developmental origins
Phillips, J. E., Couper, J., Penno, M. A. S., Harrison, L. C., & ENDIA Study Group (2016) · Pediatric Diabetes · doi:10.1111/pedi.12425 · Cited by 16
“Children with islet autoimmunity who progress to type 1 diabetes have shown an increased Bacteroidetes:Firmicutes Phyla ratio, a lower proportion of butyrateproducing bacteria, and reduced bacterial diversity.(24,25) Despite the considerable differences conferred by geographical locations and ethnicities, dysbiosis wi…”
BackgroundMetaBMF: a scalable binning algorithm for large-scale reference-free metagenomic studies
Ma, T., Xiao, D., & Xing, X. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz577 · Cited by 15
Lee, S., Knotts, T. A., Goodson, M. L., Barboza, M., Wudeck, E. V., England, G., & Raybould, H. E. (2020) · Nutrients · doi:10.3390/nu12113524 · Cited by 16
“Alistipes has been associated with probiotic effects and the SCFAs propionate and acetate, suggesting a protective effect [36,37].”
BackgroundEffect of dietary selenium intake on gut microbiota in older population in Enshi region
Zhang, Z.-X., Xiang, H., Sun, G., Yang, Y., Chen, C., & Li, T. (2021) · Genes and Environment · doi:10.1186/s41021-021-00220-3 · Cited by 18
“The dysbiosis of intestinal microbiota could lead to host disease such as diabetes type 1 and type 2 [9], irritable bowel syndrome [10], colonic cancer [11], and inflammatory bowel disease [12].”
BackgroundMulti-View Feature Aggregation for Predicting Microbe-Disease Association
Peng, W., Liu, M., Dai, W., Chen, T., Fu, Y., & Pan, Y. F. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3132611 · Cited by 17
“For example, Brown et al. [31] report that at the phylum level Bacter-oidetes, and Proteobacteria were significantly higher in T1D cases than healthy non-T1D prone subjects, which our model predicts to be the two most possible candidate microbes for T1DM.”
BackgroundInfluential
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.